Cargando…

Epigenetic memory contributing to the pathogenesis of AKI-to-CKD transition

Epigenetic memory, which refers to the ability of cells to retain and transmit epigenetic marks to their daughter cells, maintains unique gene expression patterns. Establishing programmed epigenetic memory at each stage of development is required for cell differentiation. Moreover, accumulating evid...

Descripción completa

Detalles Bibliográficos
Autores principales: Tanemoto, Fumiaki, Nangaku, Masaomi, Mimura, Imari
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9532834/
https://www.ncbi.nlm.nih.gov/pubmed/36213117
http://dx.doi.org/10.3389/fmolb.2022.1003227
_version_ 1784802207377391616
author Tanemoto, Fumiaki
Nangaku, Masaomi
Mimura, Imari
author_facet Tanemoto, Fumiaki
Nangaku, Masaomi
Mimura, Imari
author_sort Tanemoto, Fumiaki
collection PubMed
description Epigenetic memory, which refers to the ability of cells to retain and transmit epigenetic marks to their daughter cells, maintains unique gene expression patterns. Establishing programmed epigenetic memory at each stage of development is required for cell differentiation. Moreover, accumulating evidence shows that epigenetic memory acquired in response to environmental stimuli may be associated with diverse diseases. In the field of kidney diseases, the “memory” of acute kidney injury (AKI) leads to progression to chronic kidney disease (CKD); epidemiological studies show that patients who recover from AKI are at high risk of developing CKD. The underlying pathological processes include nephron loss, maladaptive epithelial repair, inflammation, and endothelial injury with vascular rarefaction. Further, epigenetic alterations may contribute as well to the pathophysiology of this AKI-to-CKD transition. Epigenetic changes induced by AKI, which can be recorded in cells, exert long-term effects as epigenetic memory. Considering the latest findings on the molecular basis of epigenetic memory and the pathophysiology of AKI-to-CKD transition, we propose here that epigenetic memory contributing to AKI-to-CKD transition can be classified according to the presence or absence of persistent changes in the associated regulation of gene expression, which we designate “driving” memory and “priming” memory, respectively. “Driving” memory, which persistently alters the regulation of gene expression, may contribute to disease progression by activating fibrogenic genes or inhibiting renoprotective genes. This process may be involved in generating the proinflammatory and profibrotic phenotypes of maladaptively repaired tubular cells after kidney injury. “Priming” memory is stored in seemingly successfully repaired tubular cells in the absence of detectable persistent phenotypic changes, which may enhance a subsequent transcriptional response to the second stimulus. This type of memory may contribute to AKI-to-CKD transition through the cumulative effects of enhanced expression of profibrotic genes required for wound repair after recurrent AKI. Further understanding of epigenetic memory will identify therapeutic targets of future epigenetic intervention to prevent AKI-to-CKD transition.
format Online
Article
Text
id pubmed-9532834
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-95328342022-10-06 Epigenetic memory contributing to the pathogenesis of AKI-to-CKD transition Tanemoto, Fumiaki Nangaku, Masaomi Mimura, Imari Front Mol Biosci Molecular Biosciences Epigenetic memory, which refers to the ability of cells to retain and transmit epigenetic marks to their daughter cells, maintains unique gene expression patterns. Establishing programmed epigenetic memory at each stage of development is required for cell differentiation. Moreover, accumulating evidence shows that epigenetic memory acquired in response to environmental stimuli may be associated with diverse diseases. In the field of kidney diseases, the “memory” of acute kidney injury (AKI) leads to progression to chronic kidney disease (CKD); epidemiological studies show that patients who recover from AKI are at high risk of developing CKD. The underlying pathological processes include nephron loss, maladaptive epithelial repair, inflammation, and endothelial injury with vascular rarefaction. Further, epigenetic alterations may contribute as well to the pathophysiology of this AKI-to-CKD transition. Epigenetic changes induced by AKI, which can be recorded in cells, exert long-term effects as epigenetic memory. Considering the latest findings on the molecular basis of epigenetic memory and the pathophysiology of AKI-to-CKD transition, we propose here that epigenetic memory contributing to AKI-to-CKD transition can be classified according to the presence or absence of persistent changes in the associated regulation of gene expression, which we designate “driving” memory and “priming” memory, respectively. “Driving” memory, which persistently alters the regulation of gene expression, may contribute to disease progression by activating fibrogenic genes or inhibiting renoprotective genes. This process may be involved in generating the proinflammatory and profibrotic phenotypes of maladaptively repaired tubular cells after kidney injury. “Priming” memory is stored in seemingly successfully repaired tubular cells in the absence of detectable persistent phenotypic changes, which may enhance a subsequent transcriptional response to the second stimulus. This type of memory may contribute to AKI-to-CKD transition through the cumulative effects of enhanced expression of profibrotic genes required for wound repair after recurrent AKI. Further understanding of epigenetic memory will identify therapeutic targets of future epigenetic intervention to prevent AKI-to-CKD transition. Frontiers Media S.A. 2022-09-21 /pmc/articles/PMC9532834/ /pubmed/36213117 http://dx.doi.org/10.3389/fmolb.2022.1003227 Text en Copyright © 2022 Tanemoto, Nangaku and Mimura. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Molecular Biosciences
Tanemoto, Fumiaki
Nangaku, Masaomi
Mimura, Imari
Epigenetic memory contributing to the pathogenesis of AKI-to-CKD transition
title Epigenetic memory contributing to the pathogenesis of AKI-to-CKD transition
title_full Epigenetic memory contributing to the pathogenesis of AKI-to-CKD transition
title_fullStr Epigenetic memory contributing to the pathogenesis of AKI-to-CKD transition
title_full_unstemmed Epigenetic memory contributing to the pathogenesis of AKI-to-CKD transition
title_short Epigenetic memory contributing to the pathogenesis of AKI-to-CKD transition
title_sort epigenetic memory contributing to the pathogenesis of aki-to-ckd transition
topic Molecular Biosciences
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9532834/
https://www.ncbi.nlm.nih.gov/pubmed/36213117
http://dx.doi.org/10.3389/fmolb.2022.1003227
work_keys_str_mv AT tanemotofumiaki epigeneticmemorycontributingtothepathogenesisofakitockdtransition
AT nangakumasaomi epigeneticmemorycontributingtothepathogenesisofakitockdtransition
AT mimuraimari epigeneticmemorycontributingtothepathogenesisofakitockdtransition